The transforming growth factor β1-inducible transcription factor, TIEG1, mediates apoptosis through oxidative stress

被引:140
作者
Ribeiro, A [1 ]
Bronk, SF [1 ]
Roberts, PJ [1 ]
Urrutia, R [1 ]
Gores, GJ [1 ]
机构
[1] Mayo Med Sch Clin & Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
D O I
10.1002/hep.510300620
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Transforming growth factor beta(1) (TGF-beta(1))-inducible transcription factors have recently elicited interest because of their critical role in the regulation of cell proliferation, differentiation, and apoptosis. We have previously reported that the TGF-beta(1)-inducible transcription factor, TIEG1, induces apoptosis in a pancreas-derived cell Line. However, the mechanisms underlying the apoptotic effects of this transcription factor remain to be defined. In this study, using the TGF-beta(1)-sensitive Hep 3B cell line, we have defined the mechanistic sequence of events that characterize TIEG1-mediated apoptosis and compared these events with the changes observed during TGF-beta(1)-induced apoptosis. Both TGF-beta(1)- and TIEG1-induced cell death were accompanied by an increase in the generation of reactive oxygen species and a loss of the mitochondrial membrane potential preceding the morphological changes of apoptosis. In contrast, increases in caspase 3-like activity and glutathione (GSH) depletion occurred later in the apoptotic process, concurrent with the morphological features of apoptosis. The antioxidant, trolox, decreased the formation of reactive oxygen species and apoptosis. These results demonstrate that similar to TGF-beta(1), TTEGI induces apoptosis by a mechanism involving the formation of reactive oxygen species.
引用
收藏
页码:1490 / 1497
页数:8
相关论文
共 39 条
  • [1] Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: Evidence for a protease-dependent pathway that does not activate cysteine protease P32
    Adjei, PN
    Kaufmann, SH
    Leung, WY
    Mao, F
    Gores, GJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11) : 2588 - 2596
  • [2] Adjei PN, 1997, J CLIN INVEST, V100, P951
  • [3] BEDOSSA P, 1995, HEPATOLOGY, V21, P760, DOI 10.1002/hep.1840210325
  • [4] Chen RH, 1997, CELL GROWTH DIFFER, V8, P821
  • [5] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [6] Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-β-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth
    Cook, T
    Gebelein, B
    Mesa, K
    Mladek, A
    Urrutia, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) : 25929 - 25936
  • [7] Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites
    Costantini, P
    Chernyak, BV
    Petronilli, V
    Bernardi, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (12) : 6746 - 6751
  • [8] Smads:: Transcriptional activators of TGF-β responses
    Derynck, R
    Zhang, Y
    Feng, XH
    [J]. CELL, 1998, 95 (06) : 737 - 740
  • [9] Elmore SP, 1997, HEPATOLOGY, V26, P256
  • [10] FUJII Y, 1994, HEPATOLOGY, V20, P177